Creationist postdoc loses lawsuit

A Massachusetts federal court judge last week (April 22) dismissed the case against a researcher at the Woods Hole Oceanographic Institution who allegedly fired a postdoc in his lab because of the postdoc's creationist beliefs. The postdoc, Nathaniel Abraham, was dismissed from his position in the lab of molecular toxicologist linkurl:Mark Hahn;http://www.whoi.edu/science/B/people/mhahn/hahnm.html#Interests in November, 2004, after revealing that he believed in the literal truth of the Bible and considered evolution to be not a fact but a theory. Hahn's lab studies the evolution of molecular mechanisms of chemical signaling and adaptation to chemical exposure. Abraham filed a discrimination complaint against Hahn, which was rejected by the Massachusetts Commission against Discrimination. He then linkurl:filed suit;http://www.the-scientist.com/blog/display/53976/ against Mark Hahn and the institute last November, arguing, according to court documents, that he had been hired to work in Hahn's lab because of his expertise in zebrafish developmental biology, toxicology, and programmed cell death, and that "acceptance of evolution as scientific fact rather than theory (in contravention of his sincerely held religious beliefs) was in no way a bona fide occupational qualification of employment." The defendants, however, argued that Abraham did not file the lawsuit within the timeframe specified by law. Furthermore, the court documents stated, research in Hahn's lab "would have involved application of evolutionary principles without qualifications concerning the acceptance of evolution." Hahn's attorney declined to comment on the case; Abraham's attorney did not return a phone message requesting comment.

Creationist postdoc loses lawsuit

The Scientist ARCHIVES

Become a Member of

Meet the Author

Alla Katsnelson

Related Research Resources

Why Do Some People Get Drunk Faster Than Others?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Sex Differences in Neurological Research

New Frontiers in Vaccine Development

New Approaches for Decoding Cancer at the Single-Cell Level

Organoids as a Tool for Tissue Regeneration Research

Products

Product News

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Accelerating Mycoplasma Testing for Targeted Therapy Development